Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Cell Lung Cancer(NSCLC）

NCT07076693 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

97

Enrollment

OTHER

Sponsor class

Conditions

OligoProgressive Metastatic Disease
Non-Small Cell Lung Cancer

Interventions

PROCEDURE: Radiotherapy or Surgery
DRUG: Standard Medical Therapy

Sponsor

Shanghai Chest Hospital